Biopharma Informatic

Biopharma Informatic

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Biopharma Informatic is a US-based, private clinical research services organization founded in 2018, headquartered in San Diego with a corporate office in Houston, TX. Contrary to its name and initial sector tags, the company's core business is not AI or bioinformatics but rather operating a network of clinical trial sites and providing site management services to facilitate patient recruitment and trial execution for sponsors and CROs. It leverages a centralized system and dedicated personnel to streamline trial startup and management across multiple therapeutic areas. The company appears to be a revenue-generating services business within the clinical trial outsourcing ecosystem.

Multiple

Technology Platform

A secured centralized system and communication tools for managing clinical trial site operations, patient data, and sponsor communication. Appears to be a clinical trial management system (CTMS) rather than an AI/drug discovery platform.

Opportunities

The growing global clinical trials market and industry trend towards outsourcing site management present a significant opportunity.
Expanding its network of investigative sites and deepening therapeutic expertise can allow the company to capture more volume from sponsors and CROs seeking efficient, turnkey trial execution.

Risk Factors

Key risks include dependence on pharmaceutical R&D spending, intense competition in site management services, operational risks related to patient recruitment and regulatory compliance across a dispersed network, and potential market confusion due to a mismatch between its tech-focused branding and its service-oriented business model.

Competitive Landscape

The company competes in the fragmented clinical trial site services market against large global CROs (like IQVIA, PPD, ICON) with integrated site networks, other specialized Site Management Organizations (SMOs), and independent clinical research sites. Differentiation is based on geographic reach, therapeutic expertise, patient recruitment speed, and operational efficiency.